Literature DB >> 12681475

The unfolding tale of PECAM-1.

Denise E Jackson1.   

Abstract

Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) is a member of the immunoglobulin (Ig) superfamily that has distinctive features of an immunoreceptor based upon its genomic structure and the presence of intrinsic immunoreceptor tyrosine inhibitory motifs (ITIMs) in its ligand binding polypeptide. This has lead to its subclassification into the Ig-ITIM superfamily. Its amino-terminal Ig-like domain of PECAM-1 is necessary for its homophilic binding, which plays an important role in cell-cell interactions. Its intracellular ITIMs serve as scaffolds for recruitment of signalling molecules including protein-tyrosine phosphatases to mediate its inhibitory co-receptor activity. Increasing evidence has implicated PECAM-1 in a plethora of biological phenomena, including modulation of integrin-mediated cell adhesion, transendothelial migration, angiogenesis, apoptosis, cell migration, negative regulation of immune cell signalling, autoimmunity, macrophage phagocytosis, IgE-mediated anaphylaxis and thrombosis. In this review, we discuss some of the new developments attributed to this molecule and its unique roles in biology. Copyright 2003 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12681475     DOI: 10.1016/s0014-5793(03)00224-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  47 in total

1.  A new role for the muscle repair protein dysferlin in endothelial cell adhesion and angiogenesis.

Authors:  Arpeeta Sharma; Carol Yu; Cleo Leung; Andy Trane; Marco Lau; Soraya Utokaparch; Furquan Shaheen; Nader Sheibani; Pascal Bernatchez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08-19       Impact factor: 8.311

2.  Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.

Authors:  Mandana Mansouri; Janet Douglas; Patrick P Rose; Kristine Gouveia; Gary Thomas; Robert E Means; Ashlee V Moses; Klaus Früh
Journal:  Blood       Date:  2006-04-06       Impact factor: 22.113

3.  CD44: target for antiangiogenesis therapy.

Authors:  Horace M DeLisser
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

Review 4.  Candida albicans-endothelial cell interactions: a key step in the pathogenesis of systemic candidiasis.

Authors:  Sarah E W Grubb; Craig Murdoch; Peter E Sudbery; Stephen P Saville; Jose L Lopez-Ribot; Martin H Thornhill
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

5.  An alternatively spliced isoform of PECAM-1 is expressed at high levels in human and murine tissues, and suggests a novel role for the C-terminus of PECAM-1 in cytoprotective signaling.

Authors:  Carmen Bergom; Cathy Paddock; Cunji Gao; Trudy Holyst; Debra K Newman; Peter J Newman
Journal:  J Cell Sci       Date:  2008-04-15       Impact factor: 5.285

6.  The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis.

Authors:  Mae-Xhum Wong; John D Hayball; P Mark Hogarth; Denise E Jackson
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

7.  The prognostic value of platelet endothelial cell adhesion molecule-1 in non-small-cell lung cancer patients.

Authors:  Bo-hua Kuang; Xi-zhi Wen; Ya Ding; Rui-qing Peng; Pei-qiang Cai; Meng-qing Zhang; Feng Jiang; Xiao-shi Zhang; Xing Zhang
Journal:  Med Oncol       Date:  2013-03-15       Impact factor: 3.064

8.  Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice.

Authors:  Reema Goel; Benjamin R Schrank; Shikha Arora; Brian Boylan; Barbara Fleming; Hiroto Miura; Peter J Newman; Robert C Molthen; Debra K Newman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-31       Impact factor: 8.311

9.  Poly (lactic-co-glycolic acid) as a controlled release delivery device.

Authors:  Tee Yong Lim; Chye Khoon Poh; W Wang
Journal:  J Mater Sci Mater Med       Date:  2009-03-13       Impact factor: 3.896

10.  Cell aggregation induces phosphorylation of PECAM-1 and Pyk2 and promotes tumor cell anchorage-independent growth.

Authors:  Xing Zhang; Li-hua Xu; Qiang Yu
Journal:  Mol Cancer       Date:  2010-01-14       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.